mash and glp 1 Incretin-based therapies in MASLD/MASH: from GLP-1 receptor agonists to dual triple agonists The Emerging Role of Glucagon-Like

Polymorphisms in dipeptidyl peptidase IV gene are associated with the risk of myocardial infarction in patients with atherosclerosis

All statistics and clinical interpretations are sourced from published Phase 2 and Phase 3 trial results as of October 2025

Monitor & track your progress Stay on top of your health by visualising long-term trends and receiving real-time updates on your biomarkers directly through the app

This can lead to very low caloric intake

By monitoring Loss of Exclusivity (LOE) forecasts and performing white space analysis, facilities can identify therapeutic areas with high demand but low patent density, or identify when specific formulation patents expire, allowing for the legal production of non-infringing compounds

Dizziness and Headaches Sodium helps maintain your blood pressure